Email or call ext. 19628 for more information.

Clinical Research Week!

October 19-23, 2015

10th Annual Clinical Research Training Course October 22, 2015

"Providing the tools for effective clinical research"

Expanded course with new content!

We are currently developing a dynamic program tackling today's hot topics in clinical research, with:

  • expert panels addressing your questions about clinical research
  • fun, interactive sessions putting your knowledge to the test
  • topics that you've told us you need to know

Celebrating 10 Years!

Ten years ago, Dr. Phil Wells envisioned a clinical research training course that would bring researchers and research staff together in an effort to ensure continuing research education and a commitment to research quality. Together, we've educated, grown and advanced clinical research within the walls of The Ottawa Hospital, and for clinicians and research staff in surrounding regions.

As our valued clinical research leaders, please mark your calendars and join us for this milestone in clinical research training at The Ottawa Hospital.

Mark your calendar today.

We hope to see you there!!


Investigator Session Schedule - October 20th - General Campus

A shift in the landscape – Approaches to Patient-Oriented Research
Tuesday, October 20th 2015, The Ottawa Hospital General Campus, Room TBC

  • Grand Rounds (8am – 9am)
  • Patient-Oriented Research Panel (9am – 12 noon)

Session Objective

To inform local clinical researchers of the change in culture and approach to research which is being encouraged across Canada and to highlight organizations, working groups and local resources available to support them meet this change

Grand Rounds Dr. Susan Zickmund Institutional implementation of PCORI practices, a national strategy for engaging patients in research – the why, the how, the failures and successes
Session chaired by: Dr. Dean Fergusson
9.00 – 9.25 Dr. Vasanthi Srinivasan Canada's national and Ontario's provincial movement towards Patient-Oriented Research: Progress to date, current initiatives and horizon objectives
9.25 – 9.50 Anne Lyddiatt My role in research as a patient: My story, why I care about research and how I know it was important
9.50 – 10.10 Dr. Loes Knaapen The principles and practices of patient engagement in research.
10.10 – 10.30 Break
10.30 – 11.00 Dr. E. Marc Jolicoeur Improving trial efficiency
11.00 – 11.15 Dr. Kednapa Thavorn So often overlooked - the emergence and necessity of Health Economic Analysis in all research in Canada
11.15 – 11.30 Dr. Ray Saginur Working with Clinical Trials Ontario to improve the efficiency of trials across multiple centres
11.30 – 11.45 Dr. Lauralyn McIntyre Ontario SPOR SUPPORT Unit IMPACT Award Applicants: Engaging stakeholders in research at TOH
11.45 – 12.00 Dr. Dean Fergusson Summary and Q&A
Dr. Susan Zickmund

Dr. Susan Zickmund
Associate Professor of Medicine, University of Pittsburgh

Dr. Zickmund joined the faculty at the University of Pittsburgh in 2003. Before that, she was at the University of Iowa, where she was the principal investigator of the Patient Narrative Study, a psychosocial study examining quality of life and health outcomes. She completed 3 years of postdoctoral training at the University of Iowa Cardiovascular Center, where she explored the impact of communication problems on health outcomes in patients with congestive heart failure. Dr. Zickmund now focuses on barriers to initiating antiviral therapy for patients with hepatitis C and has received a VA merit (R01) grant to use a multisite research design to explore these barriers. She is also the director of the Qualitative Research Core at the University of Pittsburgh and the VA CHERP.

Dr. Vasanthi Srinivasan

Dr. Vasanthi Srinivasan
Founding Executive Director, Ontario Strategy for Patient-Oriented Research (SPOR) SUPPORT Unit

Until December 2013, Vasanthi was the Assistant Deputy Minister of the Health Systems Strategy and Policy Division. She was also the lead for the research program for the Ministry of Health and Long Term Care. She has held several senior management positions at the federal and provincial levels of government. Vasanthi holds a Ph.D. from the University of Ottawa and has led several key policy and research initiatives. She has served at the national and international levels in social policy areas such as health and immigration with a particular focus on seniors, aboriginal peoples and women's issues. During her tenure in the Policy Research Initiative of the Privy Council Office of Canada, she was seconded to the Cabinet Office in the United Kingdom to the Performance and Innovation Unit. While in London, she co-authored a white paper on Immigration and Integration Issues and created the Strategic Futures Group that led horizontal policy development for Whitehall, the Scottish Executive, the Welsh Assembly and Northern Ireland. Vasanthi was awarded the prestigious Head of the Public Service of Canada Award for her work on the Metropolis Project established to conduct policy research on immigration and integration in cities lead by Canada and involving 18 countries. As Assistant Deputy Minister at the Ministry of Health and Long Term Care, Vasanthi was the lead of two teams that won the coveted Amethyst Awards for the Ontario Mental Health and Addiction Strategy and for the work of the Trilateral Committee addressing First Nations and Aboriginal issues.

Dr. Loes Knaapen

Dr. Loes Knaapen
Assistant Professor, University of Ottawa

Loes Knaapen is a sociologist who conducts qualitative research on standardization and knowledge production in medicine. She examines the principles, practices and politics of Evidence Based Medicine, and has a particular interest in Patient and Public Involvement (PPI) in health care at large, including in research design, individual clinical decisions and the development of health care policy. Before becoming an assistant professor in Sociology at the University of Ottawa, she obtained her PhD from McGill University, and completed a Postdoctoral Fellowship at the Public Health Research Institute of l'Université de Montréal (IRSPUM). Since 2008 she has been an active member of the international working group on Patient & Public Involvement at the Guidelines International Network (G-I-N PUBLIC), co-authoring several chapters of G-I-N PUBLIC's Toolkit on Patient and Public Involvement in Guidelines. Her current research investigates patient and public involvement in the regulation of new pharmaceuticals at the Food and Drug Administration (FDA) in the USA. At the University of Ottawa she teaches courses in the Sociology of Health and Medicine as well as Qualitative Research Methods.

Dr. E. Marc Jolicoeur

Dr. E. Marc Jolicoeur
Assistant Professor, Université de Montréal

Dr. Jolicoeur is an interventional cardiologist specialized in advanced coronary artery disease and refractory angina at the Montreal Health Institute. Dr. Jolicouer is leading an initiative for the development of innovative clinical trials using Bayesian methods, and a national administrative database validation initiative. His research interests revolve around the development of new treatment options for patients unsuitable for revascularization. He runs a large practice of patients with refractory angina. Dr. Jolicoeur received his MD degree in 2000 from the Université de Montréal and obtained his specialty board in cardiology in 2006, followed by a fellowship at Duke University.

Dr. Kednapa Thavorn

Dr. Kednapa Thavorn
Scientist, Clinical Epidemiology Program, Ottawa Hospital Research Institute

Dr. Thavorn is a scientist and a health economist with the Clinical Epidemiology Program at the Ottawa Hospital Research Institute, The Ottawa Hospital. She received her bachelor's in Pharmacy from Chiang Mai University and master's degrees in Pharmacy from Naresuan University, Thailand. She earned a doctoral degree in Health Services Research from the Institute of Health Policy, Management and Evaluation (IHPME), University of Toronto. She completed two post-doctoral fellowship programs, including Applied Pharmacoeconomics from the Li Ka Shing Knowledge Institute, St. Michael's Hospital and Health Services Research from IHPME, University of Toronto.

Dr. Raphael Saginur

Dr. Raphael Saginur
Chair of the Ottawa Health Science Network Research Ethics Board

Dr. Saginur is an Infectious Disease physician at the Ottawa Hospital and Associate Professor of Medicine at the University of Ottawa. He graduated from Dartmouth College (A.B., 1969) and the Faculty of Medicine, McGill University (M.D.C.M., 1973) and trained in Internal Medicine, Infectious Diseases, and Medical Microbiology at McGill and Tufts Universities, the latter under Drs. John Bartlett and Sherwood Gorbach. He began his independent career at the Jewish General Hospital and McGill University in Montreal, moving to the Ottawa Civic Hospital (now The Ottawa Hospital) and the University of Ottawa in 1983.

In the area of Infectious Diseases, he has been involved in clinical trials and laboratory studies mostly related to bacterial infections, with a particular interest in bacterial biofilms and surgical infections. He served as President of the Canadian Foundation for Infectious Diseases and was President of the 26th International Congress of Chemotherapy in Toronto in 2009. He is Treasurer of the International Society of Chemotherapy and a Director of the Society. He has been actively involved in the public health-infectious diseases interface in areas such as emergency preparedness, travel medicine and antibiotic resistance and stewardship. Dr. Saginur was the founding President of the Canadian Association of Research Ethics Boards and led the initial development of the Ontario Cancer Research Ethics Board, of which he chairs the Governance Committee. He is a director of Clinical Trials Ontario. He is actively involved in studies of research ethics, particularly around areas of consent and impact of innovative clinical trials designs. He has been honoured with Meritorious Membership of the International Society of Chemotherapy and the President's Award of the Canadian Association of Research Ethics Boards.

Dr. Lauralyn McIntyre

Dr. Lauralyn McIntyre
Scientist, Clinical Epidemiology Program, Ottawa Hospital Research Institute

Dr. McIntyre is an Intensivist at the Ottawa Hospital, Associate Professor in the Department of Medicine at the University of Ottawa and a Scientist with the Clinical Epidemiology Program at the Ottawa Hospital Research Institute. She is the ICU Research Chair at the Ottawa Hospital and a member of the Canadian Critical Care Trials and Translational Biology Groups. Dr. McIntyre's research interests focus on resuscitation, transfusion, and the use of stem cells in the critically ill. She has conducted observational studies, surveys, meta-analyses, and clinical trials that examine fluid resuscitation in the septic shock setting as well as the use of red blood cells, fresh frozen plasma, and transfusion alternatives in the critically ill. She is the lead investigator on a transitional program of research that aims to examine the safety and optimal dose of mesenchymal stem cells for the treatment of septic shock.

Dr. Dean Fergusson

Dr. Dean Fergusson
Director, Clinical Epidemiology Program, Ottawa Hospital Research Institute

Dr. Fergusson is a Senior Scientist & Director, Clinical Epidemiology Program, at the Ottawa Hospital Research Institute. He is also a Full Professor, Departments of Medicine, Surgery, & of Epidemiology and Community Medicine, University of Ottawa. Dr. Fergusson holds the position of Endowed Chair, OHRI/uOttawa, Clinical Epidemiology Program. He holds a PhD (Honours) in Epidemiology and Biostatistics from McGill University and a Masters of Health Administration from the University of Ottawa. Dr. Fergusson's clinical research interests are mainly in the field of transfusion medicine with a focus on transfusion alternatives and the effectiveness of blood products. His research interests also extend to the methodology and ethics of clinical trials and systematic reviews. Dr. Fergusson is a principal investigator on a number of large, peer-reviewed clinical trials in transfusion medicine including "Blood Conservation Using Antifibrinolytics: Randomized Trial in High-Risk Cardiac Surgery (BART)", Age of Red Blood Cells in Premature Infants (ARIPI), "Age of Blood Evaluation (ABLE)". Dr. Fergusson has contributed over 350 articles, abstracts, and book chapters to the medical literature.

Investigator Session Registration - October 20th


Nursing Research Day Schedule - October 21st

Location: The Ottawa Hospital, General Campus, CCW 5225
Time: 0800 to 1600 hours

8.00 - 8.30 Dr. Kathy Momtahan, RN, PhD
Corporate Nursing Research Lead. NPPD, The Ottawa Hospital Senior Clinician Investigator, Clinical Epidemiology Program (CEP) Ottawa Hospital Research Institute
Registration and introduction to the day
Review of the research process
8.30 - 10.00 Session Leader: Janet Yamada, RN, PhD, Post-doctoral Fellow, OHRI Finding and interpreting systematic reviews
Quantitative research methods in a hospital environment
10.00 - 10.15 Break
10.15 - 10.45 Session Leader: Chantelle Garritty, BA, DCS, MSC, Senior Operations Manager | Ottawa Methods Centre OHRI Methods Centre: Services offered, service activation, cost, and project management
10.45 - 11.15 Session Leader: Bev Shea, PhD, Senior Research Associate, Ottawa Methods Centre/OHRI Ontario's strategy for patient-oriented research
11.15 - 12.15 Session Leader: Jean Daniel Jacob, RN, PhD, Associate Professor, University of Ottawa School of Nursing Qualitative research methods
12.15 - 13.00 Lunch
13.00 - 13.30 Session Leader: Linda Longpre, CCRP, Manager, REB Administrative Office, OHSN-REB The ethics review process – How to be efficient and prevent delays
13.30 - 14.15 Session Leader: Lynn Gagné, RN, CCRP Clinical Research Auditor/Facilitator, OHRI Best practices in research project record-keeping and requirements for the conduct of research at the hospital
14.15 - 14.45 Break
14.45 - 15.45 Session Leader: Kelly Cobey, PhD
Senior Clinical Research Associate (Publications Officer)
Knowledge Synthesis Group
Ottawa Methods Centre
Clinical Epidemiology Program
How to get published effectively
15.45 - 16.00 Dr. Kathy Momtahan, RN, PhD Wrap up and evaluations

Nursing Research Day Registration - October 21st

Please note: The Nursing Research Day is most valuable for nurses with some experience as a Principal Investigator or Co-Investigator on a research study.

Max. 250 characters allowed.

Thursday full day Schedule - October 22nd - General Campus

Plenary Session 8.30 – 9.15 Karen Arts Initiatives to Streamline Clinical Trials
9.15 – 10.00 Maria Judd The Canadian Foundation for Healthcare Improvement – Our experience in benefiting from Patient Partnerships
10.00 – 10.20 Break
10.20 – 11.00 Hilda Bastian In this era of evidence-based medicine – improving health equity, the efficiency of clinical trials and the applicability of our work
11.00 – 12.00 David Moher Bench marking increases in research value and reductions in waste: the REWARD observatory
12.00 – 1.00 Lunch
Workshop 1 1.00 – 4.15
(includes break)
Dr. Bev Shea,
Maria Judd &
Sandra Schmidt

Problem based learning session to explore patient-engagement and approaches to patient-oriented research.

Covering aspects such as:

  • Improving communication
  • Recruiting, training and empowering patient researchers
  • Soliciting perspectives and integrating ideas into projects
  • Evaluation frameworks for PE
Workshop 2 1.00 – 3.00 Kelly Cobey How to publish fit-for-purpose manuscripts: Advice from the Publications Officer
3.15 – 4.15 Jenn Ganton Science and the Media
Workshop 3 1:00 – 2:00 Marc Venturi Trial Management
2.00 – 3.00 Marc Venturi Trial Budgets
3.15 – 4.15 Penny Phillips &
Josee Champagne
Multi-Centre Trials
Karen Arts

Karen Arts
Executive Director of the Canadian Cancer Clinical Trials Network Chair of Network of Networks

Karen holds Masters and Bachelors of Science degrees in Nursing. She graduated with Honours and is a member of Sigma Theta Tau, the Honour Society of Nursing. Karen is certified in several areas, including Oncology, Clinical Research, Nursing Management and Administration, Palliative care, Obstetrics and Gynecology. She has thirty-six years of professional experience, in the Netherlands and in Canada, both in the pharmaceutical industry and in the public health system in a variety of positions, with a focus on Oncology and clinical research. In the pharmaceutical industry, Karen was employed in several positions in clinical development, operations, and medical communications areas. In the public health system her positions have ranged from staff nurse to educator, nurse-manager, research coordinator and manager; and director. Karen is one of the founding members and chair of the board of directors of the Network of Networks (N2), a not for profit organization, which aims to enhance Canada's clinical research capability and capacity, by providing clinical research professionals with the necessary tools and programs to conduct high quality research with integrity, efficiency and continuous quality improvement; acting as a national voice, advocating on behalf of membership for issues affecting or influencing clinical research in Canada; and serving as a national alliance, bridging regional and provincial initiatives. N2 fosters collaboration among stakeholder groups to strengthen Canada's research enterprise.

Maria Judd

Maria Judd
Senior Director, Patient Engagement and Improvement

Maria Judd is responsible for developing and implementing strategies, programs and activities in support of CFHI's mission, and leading business development initiatives. Maria's passion for healthcare improvement has evolved from her diverse roles within the health system, such as a community health centre board member, clinician, program manager and researcher. She has extensive experience in knowledge transfer and exchange, establishing and promoting new ventures, creating education programs, developing clinical practice guidelines and convening expert groups. Prior to joining CFHI in 2005, Maria worked in a variety of health-related organizations. As the best practices program manager for the Canadian Physiotherapy Association, she designed a program of activities to support evidence-informed practices among members and their colleagues. She also coordinated the Cochrane Collaboration's Musculoskeletal Group at the University of Ottawa where much of her work focused on the development of evidence-based resources, such as systematic reviews, and supporting knowledge translation activities. Maria holds a Master of Science in Epidemiology and Community Medicine from the University of Ottawa and a Bachelor of Science in Physical Therapy from the University of Toronto.

Hilda Bastian

Hilda Bastian
National Institutes of Health

Hilda was a long-time consumer advocate in Australia, whose career turned to analyzing evidence, communicating about it, and working to make it more accessible. Hilda now works at the National Institutes of Health (NIH) in the US, at the National Center for Biotechnology Information (NCBI) in the National Library of Medicine (NLM). She is editor of PubMed-related projects on clinical effectiveness and post-publication evaluation, PubMed Health and PubMed Commons. She arrived at the NIH in 2011 after 7 years in Germany helping establish IQWiG, a national health technology assessment agency. She was the head of its Department of Health Information. Before that, during the 1990s and 2000s, Hilda was active locally, nationally, and internationally in health consumer groups, including time as the Chairperson of the Consumers' Health Forum, of which she is an honorary lifetime member. She helped to establish the Cochrane Collaboration, founding and leading its Consumer Network for over a decade. She was the first Coordinating Editor of Cochrane's Consumer and Communication Review Group. Hilda is a committed and enthusiast Wikipedian, academic editor of PLOS Medicine, and member of PLOS One's human research ethics advisory group. She cartoons and blogs about clinical epidemiology, evidence, and uncertainties.

David Moher

David Moher
Senior Scientist, OHRI

Dr. David Moher is a Senior Scientist with the Ottawa Methods Centre, Clinical Epidemiology Program, Ottawa Health Research Institute (OHRI) an Associate Professor in the Department of Epidemiology and Community Medicine at the University of Ottawa and holds a University Research Chair. Dr. Moher has a Masters degree in Epidemiology and a PhD in Clinical Epidemiology and Biostatistics. Dr. Moher has an H-index of 83 (Google scholar) which indicates his research is cited and been used to inform policy; he was recently recognized as one of the most highly cited researchers by Thomson Reuters (The World's Most Influential Scientific Minds ); according to a recent publication he is one of the most influential researchers in biomedicine (top 0.03% - Boyack KW et al. A list of highly influential biomedical researchers, 1996-2011. EJCI 2013;43:1339-1365). Dr. Moher is a member of the advisory board for the International Congress on Peer Review and Biomedical Publication. He's a member of editorial boards of several medical journals and other editorial functions, such as membership on PLoS one's Human Research Advisory Board.Dr. Moher is the founding editor-in-chief of Systematic Reviews.

Bev Shea

Bev Shea
Senior Methodologist, OHRI

Bev Shea has been involved in the production of more than 40 systematic Reviews. And more recently, has contributed to the creation of new knowledge in the field of quality assessment and qualitative data analysis. This includes the development of an original quality assessment instrument for assessing systematic reviews known as "AMSTAR". She is an editor for the Cochrane Musculoskeletal Review Group, and co-convenor for the Cochrane non-randomized methods working group. She is a Clinical Scientist at the Bruyère Research Institute, Senior Methodologist at the Ottawa Health Research Institute, and Adjunct Professor at the Department of Epidemiology and Community Medicine at the University of Ottawa.

Dr. Kelly Cobey

Dr. Kelly Cobey
Senior Research Associate

Kelly is a Senior Research Associate with the Knowledge Synthesis Group. In her capacity as Publications Officer she works to promote the use of reporting guidelines for authors writing manuscripts, peer reviewers and scientific journal editors. She obtained her PhD in Psychology (University of Groningen, The Netherlands) and has an MSc in Biology (University of Liverpool, England) and BSc in Psychology and Biology (McMaster University, Canada). To date, her research has focused on how endocrine changes across the female lifespan contribute to wellbeing. She has used a range of methods to address this topic, but has specific training and experience working in clinical trials. Prior to her current post Kelly worked as a Lecturer at The University of Stirling (Scotland) and held a Fyssen Research Fellowship (France).

Thursday full day Registration - October 22nd

Group discounts are available for those who register together

  • 25% off for 5 people or more
  • Please call (613) 798-5555 x 19628 to request group discounts.

Cost (in Canadian dollars)

  • $200 for full day
  • Note: lunch and coffee/snacks are included in the fee
  • Certificates of completion will be offered to attendees.

Note: Certificates of completion will be offered to attendees

Max. 250 characters allowed.

1.00 – 4.15
(includes break)
Dr. Bev Shea and guests
Maria Judd Sandra Schmidt
What are Patient Engagement / Patient-Oriented Research Methods (various approaches)
This will be a problem based learning session
1.00 – 3.00 Kelly Cobey Journalology II
3.15 – 4.15 Jenn Ganton Science and the Media
1:00 – 2:00 Marc Venturi Project Management
2.00 – 3.00 Penny Phillips and Josee Champagne Multi-Centre Trials
3.15 – 4.15 Marc Venturi Budgets